From: Hypomagnesemia in intestinal lymphangiectasia: a case report and review of the literature
Authors | Age/sex | Clinical manifestations | Magnesium (mmol/L) | Total calcium (mmol/L) | Corrected calcium* (mmol/L) | Albumin (g/L) | Potassium (mmol/L) | Primary/secondary to | Managements |
---|---|---|---|---|---|---|---|---|---|
Alshikho et al. [2] | 24 years/M | Diarrhea, abdominal pain, nausea/vomiting, edema, recurrent infection | 0.85 | 1.98 | 2.36 | 21 | 3.8 | Primary | MCT diet, octreotide |
Altın et al. [4] | 34 years/F | Dyspnea, edema | ↓ | – | – | ↓ | ↓ | Primary | MCT diet, octreotide |
Lu et al. [5] | 34 years/F | Diarrhea, nausea/vomiting, edema, tetany | 0.53 | 1.72 | 2.13 | 19.6 | – | Primary | MCT diet, IV albumin |
O’Donnell et al. [6] | 16 years/F | Diarrhea, edema, peripheral paresthesia, seizure, hypoparathyroidism | 0.42 | 1.2 | 1.66 | 17 | 3.3 | Primary | Calcium supplementation |
Orbeck et al. [7] | 3 months/F | Irritation, edema, vomiting | 0.20 | 1.4 | 1.88 | 16 | 3.9 | Primary | MCT diet, IV albumin/electrolytes |
Ozeki et al. [8] | 12 years/M | Diarrhea, abdominal pain, edema, weakness, tetany | 0.38 | – | 2.03 | 14 | – | Primary | Low-fat diet, IV albumin, propranolol, everolimus |
Troskot et al. [9] | 42 years/M | Seizure, edema, diarrhea, weight loss | 0.46 | 1.26 | 1.78 | 14 | – | Primary | MCT diet, IV albumin/electrolytes, octreotide |
Licinio et al. [10] | 17 years/F | Edema, ascites, liver fibrosis | ↓ | – | – | ↓ | – | Primary | Nutritional therapy |
Klingenberg et al. [11 | 27 years/F | Dyspnea, edema, diarrhea tetany | 0.35 | 1.07 | 1.49 | 19 | 2.82 | Primary | Dietary management, IV albumin, octreotide |
Gumà et al. [12] | 34 years/F | Edema, tetany, extensive warts | ↓ | ↓ | – | ↓ | – | Primary | MCT diet, mineral supplements |
Lu et al. [13] | 4 years 8 months/F | Diarrhea, edema, tetany | 0.92 | 2.00 | 2.28 | 25.8 | – | Primary | MCT diet, IV multiple vitamins |
Koçak et al. [14] | 47 years/F | Malaise, weakness, edema | 0.6 | 1.75 | 2.38 | 21 | – | Primary | MCT diet |
Hennekam et al. [15] | Young man | Lymphedema, facial anomalies, mental retardation | 0.65 | 1.9 | 2.28 | 21 | 3.2 | Primary (as a component of Hennekam syndrome) | MCT diet, IV albumin, nutrient supplement |
Hennekam et al. [15] | Young women | Edema, seizure, recurrent infections | 0.68 | 1.98 | 2.44 | 17 | – | Primary (as a component of Hennekam syndrome) | – |
Köstel-Bal et al. [16] | 2 months/M | Diarrhea, fever, edema | 0.46 | 1.26 | 1.78 | 14 | – | Primary | MCT diet |
Van Biervliet et al. [17] | 5 months/M | tonic-clonic seizures, irritability | 0.43 | – | 1.45 | 25 | – | Primary | MCT diet, IV albumin, nutrient supplement |
Huppke et al. [18] | 10 years/M | Diarrhea, swelling, mental retardation, facial anomaly, muscle weakness | Normal | Normal |  | Normal |  | Primary (as a manifestation of Hennekam syndrome) | – |
8 years/M | Mental retardation, facial anomaly, hyperactivity | Normal | Normal |  | Normal |  | Primary (as a manifestation of Hennekam syndrome) | – | |
Hamada et al. [19] | 4 months/M | Diarrhea, muscle weakness, convulsion, slow development | 0.29 | 1.15 | 1.63 | 16 | 3.2 | Primary | MCT diet, nutrient supplements |
Zimmet et al. [20] | 33 years/F | Recurrent infections, diarrhea, edema, tetany, lassitude | 0.25 | 1.50 | 2.18 | 6 | – | Primary | Gluten-free diet, calcium/vitamin D/magnesium supplements |
Eisner et al. [21] | 13 years/M | Edema, diarrhea, mental retardation, absence of IgA | 1.00 | 2.58 | 3.05 | 16.3 | – | Primary | Low-fat diet, IV albumin |
Scully et al. [22] | 70 years/F | Dyspnea, edema, plural effusions | 1.6 | 2.4 | 2.86 | 17 | 2.9 | Unlikely primary | – |
Bereket et al. [23] | 8.5 years/F | Steatorrhea, tetany | 0.70 | 1.73 | – | Normal | – | Primary (as a probable component of APS-1) | Steroid replacement, intensive vitamin D supplement, magnesium injection |